Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 AJR Am J Roentgenol
2 Ann Oncol
4 Ann Surg Oncol
2 BMC Cancer
1 Br J Cancer
1 Breast Cancer Res
12 Breast Cancer Res Treat
4 Breast J
4 Cancer
1 Cancer Lett
1 Cancer Res
1 Carcinogenesis
1 Curr Treat Options Oncol
3 Eur J Cancer
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 Lancet Oncol
2 N Engl J Med
1 NPJ Breast Cancer
1 Oncogene
3 Oncol Rep
3 PLoS One

    AJR Am J Roentgenol

  1. LEE CS, Moy L, Joe BN, Sickles EA, et al
    Screening for Breast Cancer in Women Age 75 Years and Older.
    AJR Am J Roentgenol. 2017 Nov 7:1-8. doi: 10.2214/AJR.17.18705.
    >> Share

    Ann Oncol

  2. PATEL R, Maxwell S, Yan D, Dressler EV, et al
    Medical Oncologists' Perception of Anti-Estrogen Therapy Benefit in Premenopausal Women with Hormone Receptor-Positive Early Breast Cancer.
    Ann Oncol. 2017 Nov 2. doi: 10.1093.
    >> Share

  3. SESTAK I, Smith SG, Howell A, Forbes JF, et al
    Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.
    Ann Oncol. 2017 Nov 6. doi: 10.1093.
    >> Share

    Ann Surg Oncol

  4. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Reply to "Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions".
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6173.
    >> Share

  5. HARNESS JK, Davies K, Via C, Brooks E, et al
    Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6130.
    >> Share

  6. COOPEY SB, Specht MC
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-Excision Rates in Breast Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6189.
    >> Share

    Vitamin D Levels Affect Breast Cancer Survival Rates.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6159.
    >> Share

    BMC Cancer

  8. QUINTERO M, Adamoski D, Reis LMD, Ascencao CFR, et al
    Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
    BMC Cancer. 2017;17:727.
    >> Share

  9. MINICHILLO S, Gallelli I, Barbieri E, Cubelli M, et al
    Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report.
    BMC Cancer. 2017;17:722.
    >> Share


  10. DIMITRAKOPOULOU VI, Tsilidis KK, Haycock PC, Dimou NL, et al
    Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    BMJ. 2017;359:j4761.
    >> Share

  11. MAYOR S
    Risk of breast cancer recurrence remains for years after endocrine treatment ends, study finds.
    BMJ. 2017;359:j5167.
    >> Share

    Number of UK patients with metastatic breast cancer isn't known.
    BMJ. 2017;359:j5205.
    >> Share

    Br J Cancer

  13. O'SULLIVAN D, Dowling P, Joyce H, McAuley E, et al
    A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
    Br J Cancer. 2017;117:1326-1335.
    >> Share

    Breast Cancer Res

  14. BROUCKAERT O, Rudolph A, Laenen A, Keeman R, et al
    Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
    Breast Cancer Res. 2017;19:119.
    >> Share

    Breast Cancer Res Treat

  15. LYNCE F, Blackburn MJ, Cai L, Wang H, et al
    Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.
    Breast Cancer Res Treat. 2017 Nov 8. doi: 10.1007/s10549-017-4563.
    >> Share

  16. SOPIK V, Sun P, Narod SA
    Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
    Breast Cancer Res Treat. 2017 Nov 8. doi: 10.1007/s10549-017-4572.
    >> Share

  17. KWA M, Li X, Novik Y, Oratz R, et al
    Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
    Breast Cancer Res Treat. 2017 Nov 9. doi: 10.1007/s10549-017-4570.
    >> Share

  18. NYROP KA, Deal AM, Choi SK, Wagoner CW, et al
    Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer.
    Breast Cancer Res Treat. 2017 Nov 9. doi: 10.1007/s10549-017-4565.
    >> Share

  19. FREEDMAN RA, Tolaney SM
    Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a review.
    Breast Cancer Res Treat. 2017 Nov 4. doi: 10.1007/s10549-017-4560.
    >> Share

  20. KIRKHAM AA, Eves ND, Shave RE, Bland KA, et al
    The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT.
    Breast Cancer Res Treat. 2017 Nov 6. doi: 10.1007/s10549-017-4554.
    >> Share

  21. LAMBERT LK, Balneaves LG, Howard AF, Gotay CC, et al
    Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
    Breast Cancer Res Treat. 2017 Nov 6. doi: 10.1007/s10549-017-4561.
    >> Share

  22. RIMAWI MF, De Angelis C, Contreras A, Pareja F, et al
    Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
    Breast Cancer Res Treat. 2017 Nov 7. doi: 10.1007/s10549-017-4533.
    >> Share

  23. MURPHY BL, Zalewski NL, Degnim AC, McKeon A, et al
    Breast cancer-related paraneoplastic neurologic disease.
    Breast Cancer Res Treat. 2017 Nov 7. doi: 10.1007/s10549-017-4566.
    >> Share

  24. GOING CC, Alexandrova L, Lau K, Yeh CY, et al
    Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
    Breast Cancer Res Treat. 2017 Nov 7. doi: 10.1007/s10549-017-4562.
    >> Share

  25. EVANS DG, Harkness EF, Howel S, Woodward ER, et al
    Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2017 Nov 7. doi: 10.1007/s10549-017-4557.
    >> Share

  26. BRIANESE RC, Nakamura KDM, Almeida FGDSR, Ramalho RF, et al
    BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
    Breast Cancer Res Treat. 2017 Nov 7. doi: 10.1007/s10549-017-4552.
    >> Share

    Breast J

  27. SHAGISULTANOVA E, Mayordomo J, Elias AD
    Triple-negative breast cancer in the elderly.
    Breast J. 2017;23:627-629.
    >> Share

  28. SALERNO C, Vento AR, Giacchino M, Lissidini G, et al
    Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12944.
    >> Share

  29. HLUBOCKY J, Bhavnagri S, Swinford A, Mitri C, et al
    Does the use of pretreatment MRI change the management of patients with newly diagnosed breast cancer?
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12946.
    >> Share

  30. LEE AY, Joe BN, Price ER
    The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?
    Breast J. 2017;23:501-503.
    >> Share


  31. OHRI N, Sittig MP, Tsai CJ, Hwang ES, et al
    Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31080.
    >> Share

    Reply to Imaging modalities for the detection of distant metastases in breast cancer patients diagnosed in the 1970s and 1990s: Does it make any sense?
    Cancer. 2017 Nov 6. doi: 10.1002/cncy.21924.
    >> Share

  33. MANNEVILLE F, Rotonda C, Conroy T, Bonnetain F, et al
    The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer.
    Cancer. 2017 Nov 8. doi: 10.1002/cncr.31108.
    >> Share

    Imaging modalities for the detection of distant metastases in breast cancer patients diagnosed in the 1970s and 1990s: Does it make any sense?
    Cancer. 2017 Nov 6. doi: 10.1002/cncy.21925.
    >> Share

    Cancer Lett

  35. BAI XY, Li S, Wang M, Li X, et al
    Kruppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion.
    Cancer Lett. 2017;412:224-235.
    >> Share

    Cancer Res

  36. DAVIES H, Morganella S, Purdie CA, Jang SJ, et al
    Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.
    Cancer Res. 2017;77:4755-4762.
    >> Share


  37. MUTI P, Donzelli S, Sacconi A, Hossain A, et al
    MiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study.
    Carcinogenesis. 2017 Nov 4. doi: 10.1093.
    >> Share

    Curr Treat Options Oncol

  38. LA BELLE A, Khatib J, Schiemann WP, Vinayak S, et al
    Role of Platinum in Early-Stage Triple-Negative Breast Cancer.
    Curr Treat Options Oncol. 2017;18:68.
    >> Share

    Eur J Cancer

  39. ANDERSON RA, Mansi J, Coleman RE, Adamson DJA, et al
    The utility of anti-Mullerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
    Eur J Cancer. 2017;87:58-64.
    >> Share

  40. FORISSIER V, Tallet A, Cohen M, Classe JM, et al
    Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort.
    Eur J Cancer. 2017;87:47-57.
    >> Share

  41. LE RHUN E, Bertrand N, Dumont A, Tresch E, et al
    Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
    Eur J Cancer. 2017 Nov 2. pii: S0959-8049(17)31346.
    >> Share

    Int J Cancer

  42. BARRDAHL M, Canzian F, Gaudet MM, Gapstur SM, et al
    A comprehensive analysis of polymorphic variants in steroid hormone and IGF-1 metabolism and risk of in situ breast cancer: results from the Breast and Prostate Cancer Cohort (BPC3) Consortium.
    Int J Cancer. 2017 Nov 7. doi: 10.1002/ijc.31145.
    >> Share

    Int J Radiat Oncol Biol Phys

  43. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    >> Share

  44. VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
    Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:859-866.
    >> Share

    J Biol Chem

  45. DELIGIO JT, Lin G, Chalfant CE, Park MA, et al
    Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.
    J Biol Chem. 2017;292:17909-17918.
    >> Share

    Lancet Oncol

  46. GOURD E
    Thermography should not be used in breast cancer screening.
    Lancet Oncol. 2017 Nov 2. pii: S1470-2045(17)30833.
    >> Share

    N Engl J Med

  47. PAN H, Gray R, Braybrooke J, Davies C, et al
    20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
    N Engl J Med. 2017;377:1836-1846.
    >> Share

  48. GREENE AK, Voss SD, Maclellan RA
    Liposuction for Swelling in Patients with Lymphedema.
    N Engl J Med. 2017;377:1788-1789.
    >> Share

    NPJ Breast Cancer

  49. SLAVIN TP, Maxwell KN, Lilyquist J, Vijai J, et al
    Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
    NPJ Breast Cancer. 2017;3:44.
    >> Share


  50. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    >> Share

    Oncol Rep

  51. QIU Y, Liu Y, Li WH, Zhang HQ, et al
    P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6081.
    >> Share

  52. REN P, Ren X, Cheng L, Xu L, et al
    Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer.
    Oncol Rep. 2017 Nov 1. doi: 10.3892/or.2017.6067.
    >> Share

  53. GONZALEZ-GONZALEZ A, Gonzalez A, Alonso-Gonzalez C, Menendez-Menendez J, et al
    Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in cocultures of human endothelial and breast cancer cells.
    Oncol Rep. 2017 Nov 2. doi: 10.3892/or.2017.6070.
    >> Share

    PLoS One

  54. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    >> Share

  55. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    >> Share

  56. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016